MKI67 and adrenal cortex neoplasm: It is recommended in the guidelines to use the Ki67 immunohistochemistry for every resection specimen of an adrenocortical tumor, and therapeutic strategies are suggested based on low-risk (Ki67 ≤10%) or high-risk (Ki67 >10%) stratification [32].